Skip to main content
Back to Database
Anaphylaxis InsuranceEnactedFederal Checked 8/9/2026 Official Source

No Surprises Act

United States Public Law 116-260 (H.R. 133) 2022
InsuranceEmergency TreatmentSurprise BillingAnaphylaxisFederal

Transparency & Verification

Verified from Official Source
Source AgencyNot specified
Last Updated2026-08-09
Last Verified2026-08-09
Verified ByPolicyPantry Editorial Team
Official Source URL https://www.congress.gov/bill/116th-congress/house-bill/133 Link Unconfirmed — this source may not match this law (Blocked)
Last checked: 2026-08-09 approved

Policy Pantry collects information from official and trusted public sources. Legislative information can change quickly. Always review the linked official government source for the most current details.

AI Plain-Language Summary

Click "Generate" to create an AI-powered plain-language summary of this legislation.

Summary

Federal law protecting patients from surprise medical bills for emergency services, including anaphylaxis and asthma emergency treatment, from out-of-network providers or facilities at in-network rates.

Full Description

The No Surprises Act, enacted as part of the Consolidated Appropriations Act, 2021 (H.R. 133, P.L. 116-260), took effect January 1, 2022. The law bans surprise bills for emergency services from out-of-network providers or facilities, including emergency treatment for anaphylaxis and asthma attacks. It bans out-of-network cost-sharing for emergency services and certain non-emergency services furnished at in-network facilities. The law also bans balance bills for supplemental care (such as radiology or anesthesiology) at in-network facilities. Patients are only responsible for in-network cost-sharing amounts. This law is particularly relevant for allergy and asthma patients who may receive emergency treatment for anaphylaxis or severe asthma attacks at out-of-network facilities.

Who This Bill Serves & Who's Backing It

Core Patient Populations

[object Object] AnaphylaxisInsuranceEmergency TreatmentSurprise BillingAnaphylaxisFederal

People at risk of life-threatening anaphylaxis.

Advocacy Groups Backing This Legislation

No advocacy organizations are currently tracked as backing this bill.Browse advocacy organizations →

Legislative Timeline

Signed2020-12-27
Effective Date2022-01-01

Votes & Legislative History

Legislative History & Resources

Take Action on This Law

Send a letter or generate testimony about this legislation.

Advocate Connect

See who's supporting this law, find advocates with shared goals, and combine advocacy efforts and letters to amplify your impact.

Log in to join as an advocate and connect with others supporting this law.

Be the first advocate to support this law and invite others to combine efforts.

Signed Into Law
AnaphylaxisEnacted
Signed into Law
Checked 11/7/2026 Source Active Education

Alex's Law

Prescription Asthma Inhalers and Auto-Injectable Epinephrine in Schools

Authorizes schools to stock epinephrine and albuterol inhalers and allows students to self-carry and self-administer these medications with proper documentation.

Arkansas Act 851 of 2019
Trusted Reference
Trusted Reference
AnaphylaxisRegulation
Regulation
Checked 11/7/2026 Source Active Public Accommodations

Public Access to Epinephrine

Rules and Regulations Pertaining to Public Access to Auto-Injectable Epinephrine

Allows authorized entities to acquire and maintain a supply of auto-injectable epinephrine for emergency use, provided that users complete training.

Arkansas 007.01.16 Ark. Code R. 001
Official Government Source
Official Government Source
AnaphylaxisRegulation
Regulation
Checked 11/6/2026 Unrelated Link Child Care

Public Access to Epinephrine

Public Access to Epinephrine Act

Allows authorized entities, including camps and sports venues, to acquire and stock epinephrine auto-injectors and nasal sprays for emergency use on individuals experiencing anaphylaxis, regardless of prior diagnosis.

Arkansas Act 245 (2025)
Search Official Sources
Search for source

While we strive for accuracy, information may change over time. Always double-check and verify against official sources before relying on it.

PolicyPantry

Connecting America to Allergy Knowledge, Laws, and Care.

Empowering advocates for allergy, asthma & anaphylaxis rights nationwide.

Follow @policypantry

Educational Disclaimer: The information on this platform is provided for general educational and informational purposes only. It is not medical advice and does not replace professional medical consultation, diagnosis, or treatment. Always seek the guidance of a qualified healthcare professional with any questions about a medical condition. If you are experiencing a medical emergency, call 911 immediately. While we strive for accuracy, please double-check and verify any information found here against official sources before relying on it.

Policy Pantry™ is a health policy technology platform empowering communities through legislation, advocacy, and innovation.

© 2026 Policy Pantry LLC. All Rights Reserved.